ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders.
The exact amount of the dividend will be based on the merger agreement and ARCA's estimate of how much its net cash exceeds $5 million before the merger closes, the company said.
The dividend is payable on Aug. 28 to shareholders of record on Aug. 26, the company said.
The proposed merger is expected to close on Aug. 29.
Shares of ARCA were up about 13% in recent after-hours activity.
Price: 3.3200, Change: +0.37, Percent Change: +12.54
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。